Overview

Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting

Status:
Completed

Trial end date:
2005-04-01

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to determine if dronabinol is effective in preventing or treating nausea caused by HAART (highly active anti-retroviral therapy) in HIV and AIDS patients

Phase:

Phase 2

Details

Lead Sponsor:

Solvay Pharmaceuticals

Treatments:

Dronabinol